Kimball Electronics (KE) investor relations material

Company overview and strategic positioning

• Global provider of electronics manufacturing and contract manufacturing services, specializing in high-complexity, regulated industries such as automotive, medical, and industrial markets.

• Operates 7 manufacturing locations across North America, Europe, and Asia, with over 5,500 employees and $1.49B in FY25 revenue.

• Portfolio rationalization included divesting non-core businesses and integrating medical CMO into core EMS, improving utilization and focus.

• Emphasizes long-term customer partnerships, with 77% of FY25 revenue from customers with relationships over 10 years.

• Culture centers on customer focus, people, environmental citizenship, and profit as a measure of efficiency.

Operational capabilities and market focus

• Offers integrated services across the product lifecycle: design, prototyping, NPI/TOW, manufacturing, testing, and aftermarket support.

• Specializes in advanced engineering, regulatory compliance (FDA, ISO 9001, ISO 13485), and scientific injection molding for medical devices.

• Diversified revenue: 49% automotive, 27% medical, 24% industrial in FY25.

• Automotive growth driven by vehicle electrification and electronic content; medical focus on Class II/III devices and drug delivery; industrial growth in automation and clean energy.

Financial performance and outlook

• Strong balance sheet with debt down 49% from peak, positive cash from operations for 9 consecutive quarters, and $358.5M in short-term liquidity as of March 2026.

• Affirmed FY26 guidance: net sales $1.40–$1.46B, adjusted operating income 4.2–4.5% of sales, capex $50–$60M (majority for new Indianapolis facility).

• Margin expansion expected from better capacity utilization and increased medical business share.

• Capital allocation prioritizes growth investments, especially in medical CMO, with ongoing share repurchases and potential tuck-in M&A.